Opioid receptor targeting ligands for pain management: a review and update

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.10, 2010-10, pp. : 1007-1022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen receptor ligands: a patent review update

By Paterni Ilaria Bertini Simone Granchi Carlotta Macchia Marco Minutolo Filippo

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1247-1271

Informa Healthcare

Access to resources Recommend Favorite

Kappa-opioid receptor ligands

By Husbands Stephen M

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1725-1741

Informa Healthcare

Access to resources Recommend Favorite

Hybrid Opioid/Non-Opioid Ligands in Pain Research

Current Pharmaceutical Design, Vol. 19, Iss. 42, 2013-12 ,pp. : 7435-7450

Bentham Science Publishers

Access to resources Recommend Favorite

Tapentadol in Pain Management: A μ-Opioid Receptor Agonist and Noradrenaline Reuptake Inhibitor

By Hartrick Craig T. Rozek Richard J.

CNS Drugs, Vol. 25, Iss. 5, 2011-05 ,pp. : 359-370

Adis International

Access to resources Recommend Favorite

Tritiated Opioid Receptor Ligands as Radiotracers

Current Pharmaceutical Design, Vol. 19, Iss. 42, 2013-12 ,pp. : 7461-7472

Bentham Science Publishers

Access to resources Recommend Favorite